KINGSTON, Jamaica — Ozempic, a prescription medication used to treat Type 2 diabetes, has been approved for local distribution in Jamaica.
Minister of Health and Wellness Dr. Christopher Tufton announced the approval, which will allow the medication to enter the Jamaican market.
The drug is expected to become available through private pharmacies. However, it is not immediately being introduced into the public healthcare system.
Government considers access and affordability
Tufton indicated that the Government is examining additional medications used for weight management and diabetes treatment.
These include other branded drugs and generic alternatives that could provide patients with more treatment options.
The Government may also consider assistance through the National Health Fund (NHF) to make approved treatments more affordable.
Medical supervision remains important
Ozempic contains semaglutide, which helps regulate blood sugar levels in adults with Type 2 diabetes.
The medication can also reduce appetite and support weight loss. However, Ozempic is not specifically approved for weight management in every country.
Health officials have stressed that patients should use the medication under medical supervision.
The treatment may cause side effects, including nausea, vomiting, diarrhoea and constipation. It is also unsuitable for some patients.
New lifestyle clinic established in Hanover
Meanwhile, the Government is expanding efforts to address obesity and other lifestyle-related illnesses.
A lifestyle clinic has been established at the Sandy Bay Health Centre in Hanover to provide medical guidance and support.
The initiative forms part of efforts to encourage healthier eating, physical activity and better management of chronic diseases.
Health officials continue to encourage Jamaicans to adopt healthier lifestyles alongside any prescribed medical treatment.







